Ellsworth Advisors LLC Makes New Investment in Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Ellsworth Advisors LLC initiated a position in Guardian Pharmacy Services during the third quarter, purchasing 27,990 shares valued at approximately $1.14 million, or about 0.06% of the company.
• Analyst sentiment remains broadly positive: nine analysts rate the stock a Buy and one rates it Hold, producing a “Moderate Buy” consensus and an average price target of $45.57.
• Guardian reported quarterly EPS of $0.29, exceeding estimates of $0.26, while revenue reached $351.77 million versus the $340.45 million consensus forecast.

Ellsworth Advisors LLC purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 27,990 shares of the company's stock, valued at approximately $1,141,000. Ellsworth Advisors LLC owned about 0.06% of Guardian Pharmacy Services as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. State of Alaska Department of Revenue grew its position in shares of Guardian Pharmacy Services by 105.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company's stock valued at $97,000 after buying an additional 1,229 shares during the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in Guardian Pharmacy Services during the first quarter worth about $253,000. Stephens Inc. AR acquired a new stake in Guardian Pharmacy Services during the first quarter worth about $282,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Guardian Pharmacy Services during the second quarter worth about $335,000. Finally, Arizona State Retirement System lifted its holdings in Guardian Pharmacy Services by 53.0% in the second quarter. Arizona State Retirement System now owns 8,393 shares of the company's stock worth $351,000 after acquiring an additional 2,907 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts have commented on GRDN shares. Oppenheimer lifted their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Truist Financial increased their price target on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a "buy" rating in a research report on Monday, September 21st. KeyCorp assumed coverage on Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They set an "overweight" rating and a $52.00 price target on the stock. Weiss Ratings raised Guardian Pharmacy Services from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, September 19th. Nine equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $45.57.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $39.69 on Friday. Guardian Pharmacy Services, Inc. has a 1 year low of $23.72 and a 1 year high of $48.33. The company has a market cap of $1.98 billion, a price-to-earnings ratio of 38.54, a price-to-earnings-growth ratio of 2.12 and a beta of 0.03. The firm has a fifty day moving average of $40.91 and a 200-day moving average of $39.87.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.26 by $0.03. The business had revenue of $351.77 million during the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. Analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc NYSE: GRDN is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company's services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support.

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.